The Use of Magnetic Endoscopic Imaging for Improving Quality Indicators in Outpatient Colonoscopy
NCT ID: NCT01480830
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
633 participants
INTERVENTIONAL
2012-01-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This randomized study is being done to test a new colonoscopy system called the Scope Guide that shows an exact 3-dimensional picture of how the colonoscopy is positioned in the patient's abdomen.
We hypothesize that the use of the Scope Guide for colonoscopy will improve measures of colonoscopy quality including rate of complete examination, patient comfort, polyp detection rate, insertion time, amount of sedation required, and need for abdominal compression.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Quality of Colonoscopy Using a 3D-imager
NCT00519129
Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
NCT00365534
ColoAssist vs. MEI
NCT01895504
Trial on Innovative Technologies in Colonoscopy
NCT01688557
Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients
NCT07335705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard colonoscopy
No interventions assigned to this group
Magnetic endoscopic imaging colonoscopy
Magnetic Endoscopic Imaging (MEI) colonoscopy
Colonoscopy using the Scope Guide system (Olympus Canada Inc.) by
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic Endoscopic Imaging (MEI) colonoscopy
Colonoscopy using the Scope Guide system (Olympus Canada Inc.) by
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previous incomplete or difficult colonoscopy (i.e. independent indication for use of Scope Guide).
* Colonoscopist not participating in trial.
* Current pregnancy.
* Cardiac pacemaker or any other type of implantable stimulator.
* Previous colectomy, hemicolectomy, segmental colon resection, or ileocecal resection.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald MacIntosh, MD
Role: PRINCIPAL_INVESTIGATOR
Nova Scotia Health Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Capital District Health Authority
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCT01480830
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.